Cite
Combination of PARP inhibitor and temozolomide to suppress chordoma progression.
MLA
Cao, Xiaoyu, et al. “Combination of PARP Inhibitor and Temozolomide to Suppress Chordoma Progression.” Journal of Molecular Medicine, vol. 97, no. 8, Aug. 2019, pp. 1183–93. EBSCOhost, https://doi.org/10.1007/s00109-019-01802-z.
APA
Cao, X., Lu, Y., Liu, Y., Zhou, Y., Song, H., Zhang, W., Davis, D., Cui, J., Hao, S., Jung, J., Wu, Q., Park, D. M., & Yang, C. (2019). Combination of PARP inhibitor and temozolomide to suppress chordoma progression. Journal of Molecular Medicine, 97(8), 1183–1193. https://doi.org/10.1007/s00109-019-01802-z
Chicago
Cao, Xiaoyu, Yanxin Lu, Yang Liu, Yiqiang Zhou, Hua Song, Wei Zhang, Dionne Davis, et al. 2019. “Combination of PARP Inhibitor and Temozolomide to Suppress Chordoma Progression.” Journal of Molecular Medicine 97 (8): 1183–93. doi:10.1007/s00109-019-01802-z.